Lonza - PBMCs

Appointments

Uniquity Bio Appoints Will Kane as President and CEO

Will Kane

Uniquity Bio Appoints Will Kane as President and CEO

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Geoffrey M. Glass

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Corleen Roche

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Hillstar Bio Appoints Maude Tessier, Ph.D., as Chief Operating Officer

Maude Tessier

Hillstar Bio Appoints Maude Tessier, Ph.D., as Chief Operating Officer

Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Dr. Matteo Villain

Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Medicus Pharma Ltd. Appoints Andrew Smith as Chief Operating Officer

Andrew Smith

Medicus Pharma Ltd. Appoints Andrew Smith as Chief Operating Officer

Sun Pharma Appoints Richard Ascroft as CEO for North America

Richard Ascroft

Sun Pharma Appoints Richard Ascroft as CEO for North America

NervGen Appoints Randall Kaye, MD, as Chief Medical Advisor

Randall Kaye

NervGen Appoints Randall Kaye, MD, as Chief Medical Advisor

Genesis Therapeutics Appoints Aleksandra Faust, Ph.D., as Chief Artificial Intelligence Officer

Aleksandra Faust

Genesis Therapeutics Appoints Aleksandra Faust, Ph.D., as Chief Artificial Intelligence Officer